Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yangling Daiying Biotech & Pharmaceutical Group is a prominent Chinese biotechnology company located in the Yangling Agricultural High-tech Industries Demonstration Zone in Shaanxi. The group specializes in the research, development, and large-scale manufacturing of biological products, with a core focus on immunomodulators such as transfer factors and interferons. Their product portfolio serves both the human pharmaceutical and veterinary medicine sectors, addressing a wide range of viral infections and immune system disorders. The company operates multiple GMP-certified production lines for various dosage forms, including oral solutions, capsules, and injections. Through its subsidiaries, the group integrates R&D, production, and sales to provide comprehensive biological health solutions in the domestic Chinese market. It is recognized as a key high-tech enterprise within its region, maintaining collaborations with local agricultural and medical research institutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yangling Daiying Biotech & Pharmaceutical Group.